You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Sinotau Pharmaceutical Group v. Navidea Biopharmaceuticals, Inc.

Citations: 211 F. Supp. 3d 375; 2016 U.S. Dist. LEXIS 134602; 2016 WL 5660330Docket: CIVIL ACTION NO. 15-13254-RWZ

Court: District Court, D. Massachusetts; September 29, 2016; Federal District Court

Narrative Opinion Summary

In this case, Sinotau Pharmaceutical Group filed a lawsuit against Navidea Biopharmaceuticals alleging breach of contract and tortious interference with business relations, among other claims. The dispute centers around a Binding Term Sheet signed in 2015, which granted Sinotau an exclusive license to a pharmaceutical imaging agent, NAV4694. Sinotau claims Navidea failed to fulfill its contractual obligations by not renegotiating terms with AstraZeneca, as required, and interfered with Sinotau's business relationships. Navidea moved to dismiss the claims, arguing the Binding Term Sheet was not a valid contract and that no breach occurred. The court denied Navidea's motion to dismiss Counts I, II, and III, finding that Sinotau adequately alleged a valid contract and intention to be bound by the Binding Term Sheet. The court also found sufficient allegations to proceed with the claim of tortious interference. The choice of law issue between Massachusetts and Delaware was deemed non-essential as it did not affect the outcome. The case proceeds on the grounds that the Binding Term Sheet constitutes a valid contract and that there is plausible evidence of breach and tortious interference.

Legal Issues Addressed

Breach of Contract

Application: Sinotau alleges that Navidea breached the Binding Term Sheet by failing to renegotiate the Navidea-AZ License Agreement as required, which constitutes a breach of the agreement.

Reasoning: The complaint plausibly alleges that Navidea breached this agreement... alleges that this inaction constituted a breach by failing to use best efforts in the renegotiation process.

Choice of Law in Diversity Jurisdiction

Application: The court applies the forum state's choice-of-law rules to determine whether Massachusetts or Delaware law governs the contract and tort claims, but finds no actual conflict affecting the outcome.

Reasoning: The parties dispute whether Massachusetts or Delaware law governs Sinotau’s contract and tort claims... However, the outcome remains unchanged under both laws, making a choice unnecessary.

Contract Formation and Binding Term Sheet

Application: The court finds that the Binding Term Sheet between Sinotau and Navidea constitutes a valid contract due to mutual intent to be bound, definiteness of terms, and legal consideration.

Reasoning: Sinotau has sufficiently alleged the existence of a valid contract, demonstrating mutual intent to be bound, definiteness of terms, and legal consideration.

Motion to Dismiss Standard

Application: The court considers all well-pleaded factual allegations as true and makes reasonable inferences in favor of the plaintiff when evaluating a motion to dismiss.

Reasoning: For a motion to dismiss, the court accepts all well-pleaded factual allegations as true and makes reasonable inferences in favor of the plaintiff.

Tortious Interference with Business Relations

Application: Sinotau claims that Navidea intentionally interfered with Sinotau's prospective business relationships by denying an exclusive license to NAV4694, which the court finds sufficiently pleaded to proceed.

Reasoning: Sinotau alleges it sought relationships with pharmaceutical companies for NAV4694, claiming Navidea was aware of these efforts and purposefully induced breaks in these relationships by denying an exclusive license.